Future research endeavors should prioritize exploring the role of GLAST+ in other neurodegenerative conditions, such as Parkinson’s disease, Alzheimer’s disease, Huntington’s disease, and Frontotemporal Dementia. Here, SLC1A3 is linked to Alzheimer disease.